Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Susceptibility-Guided vs. Standard Therapies for H. pylori Eradication
NCT02759029Unknown
- Sponsor
- Gangnam Severance Hospital
- Start
- Mar 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline and 1 more in Helicobacter pylori infection (3 arms), sponsored by Gangnam Severance Hospital. Primary endpoint: Eradication rate of Helicobacter pylori. Status: unknown.
02
Drugs
amoxicillinclarithromycinmetronidazolelevofloxacintetracycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02759029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02759029.